Chandra Bhagat Pharma Ltd
BSE:542934
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| IN |
C
|
Chandra Bhagat Pharma Ltd
BSE:542934
|
318.4m INR |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
119.4B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.7B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
70.5B USD |
Loading...
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.4B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
35.5B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.5B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
64.2B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
66.2B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
Market Distribution
| Min | -305 007.7% |
| 30th Percentile | 2.1% |
| Median | 5.8% |
| 70th Percentile | 11.6% |
| Max | 1 221 633.3% |
Other Profitability Ratios
Chandra Bhagat Pharma Ltd
Glance View
Chandra Bhagat Pharma Ltd. engages in the business of marketing pharmaceutical critical care & health care products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2020-02-14. The firm is engaged in the business of marketing pharmaceutical formulation and products in domestic and international markets through its distribution network and sales force under its own brand. The company is also engaged in the business of marketing pharmaceutical critical care & health care products. The company offers a wide range of product portfolio of pharmaceutical formulation including intravenous (IV) & intramuscular (IM) range injections, and a few tablets to cater the domestic & export market. The company has established presence in major therapeutic categories for formulations such as anticancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, neurology etc. The company is engaged in promoting and marketing of active pharmaceuticals ingredients (API's) in India.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Chandra Bhagat Pharma Ltd is 0.9%, which is above its 3-year median of 0.7%.
Over the last 3 years, Chandra Bhagat Pharma Ltd’s Net Margin has increased from 0.9% to 0.9%. During this period, it reached a low of 0.6% on Sep 30, 2023 and a high of 0.9% on Oct 30, 2024.
